Essential role of brain-derived neurotrophic factor in adult hippocampal function
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Brain-derived neurotrophic factor (BDNF) regulates neuronal development and function. However, it has been difficult to discern its role in the adult brain in influencing complex behavior. Here, we use a recently developed inducible knockout system to show that deleting BDNF in broad forebrain regions of adult mice impairs hippocampal-dependent learning and long-term potentiation. We use the inducible nature of this system to show that the loss of BDNF during earlier stages of development causes hyperactivity and more pronounced hippocampal-dependent learning deficits. We also demonstrate that the loss of forebrain BDNF attenuates the actions of desipramine, an antidepressant, in the forced swim test, suggesting the involvement of BDNF in antidepressant efficacy. These results establish roles for BDNF in the adult, and demonstrate the strength of this inducible knockout system in studying gene function in the adult brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, the antidepressant-like response to conventional antidepressants is attenuated in mice where the BDNF signaling has been disrupted by genetic manipulations.”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Monteggia et al., 2004
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In BDNF heterozygous knockout mice and BDNF conditional knockout mice, the behavioral response to antidepressant drugs in the forced swim test is abolished105,115,121.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In this context, BDNF has been linked to the mechanism of action of antidepressants (Duman et al., 1997; Ghosh et al., 1994; Monteggia et al., 2004; Duman and Monteggia, 2006).”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Monteggia et al., 2004
The cited source says what the claim attributes to it.
In the citing paper
“conditional knockout in the forebrain resulted in an increase in depressive-like behavior in female but not male mice (Monteggia et al. 2007) and, furthermore, decreased the efficacy of the antidepressant desipramine (Monteggia et al. 2004).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Monteggia et al. 2004
The cited source says what the claim attributes to it.
In the citing paper
“However, these mice had an attenuated response to the antidepressant desipramine suggesting forebrain BDNF was required for antidepressant efficacy (Monteggia et al., 2004).”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Monteggia et al., 2004
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859
Behavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 4,063
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Trk Receptors: Roles in Neuronal Signal Transduction
Huang, E. J., & Reichardt, L. F. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161629 · Cited by 2,537
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Neurotrophins as synaptic modulators
Poo, M.-M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35049004 · Cited by 1,775
Long-Lasting Neurotrophin-Induced Enhancement of Synaptic Transmission in the Adult Hippocampus
Kang, H., & Schuman, E. M. (1995) · Science · doi:10.1126/science.7886457 · Cited by 1,354
Patterson, S. L., Abel, T., Deuel, T. A. S., Martin, K. C., Rose, J. C., & Kandel, E. R. (1996) · Neuron · doi:10.1016/s0896-6273(00)80140-3 · Cited by 1,233
Mice lacking brain-derived neurotrophic factor develop with sensory deficits
Ernfors, P., Lee, K.-F., & Jaenisch, R. (1994) · Nature · doi:10.1038/368147a0 · Cited by 1,067
Research works printed but not linked: 2
- Rios, M., Fan, G., Fekete, C., Kelly, J., Bates, B., Kuehn, R., Lechan, R. M. & Jaenisch, R. (2001) Mol. Endocrinol. 15, 1748-1757. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
- Porsolt, R. D., Bertin, A. & Jalfre, M. (1977) Arch. Int. Pharmacodyn. Ther. 229, 327-336. [PubMed] [Google Scholar]
Cited by
Items 301–400 of 686
Galloway, E. M., Woo, N. H., & Lu, B. (2008) · Progress in brain research · doi:10.1016/s0079-6123(07)00015-5 · Cited by 67
“Intriguingly, mice with hypomorphic BDNF expression show no change in GAD67 or PV expression, suggesting that TrkB is more prevalent than BDNF in controlling the GABAergic phenotypes (Monteggia et al., 2004; Hashimoto et al., 2005).”
BackgroundWang, Y., Mathews, C. A., Li, Y., Lin, Z., & Xiao, Z. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.04.002 · Cited by 64
“One of these possiblemechanisms has been hypothesized to involve brainderived neurotrophic factor (BDNF) (Monteggia et al., 2004).”
BackgroundBrain‐Derived Neurotrophic Factor in Schizophrenia and Its Relation With Dopamine
Guillin, O., Demily, C., & Thibaut, F. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(06)78012-6 · Cited by 62
The When and Where of BDNF and the Antidepressant Response
Wang, J., Dranovsky, A., & Hen, R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.008 · Cited by 59
HCN Channel Targets for Novel Antidepressant Treatment
Ku, S. M., & Han, M.-H. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0538-7 · Cited by 54
The role of eEF2 kinase in the rapid antidepressant actions of ketamine
(2020) · Advances in Pharmacology · doi:10.1016/bs.apha.2020.04.005 · Cited by 52
Self-citationKeifer, J. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25022 · Cited by 61
Gardier, A. M. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283243fcd · Cited by 54
“Monteggia et al. (2004) used an inducible KO system to show that deleting BDNF in broad forebrain regions of adult mice also attenuates the effects of the antidepressant desipramine in the FST, indicating a role for BDNF in the adult brain in the antidepressant-like activity of this drug.”
MethodNeurobiology of Memory and Anxiety: From Genes to Behavior
Kalueff, A. V. (2007) · Neural Plasticity · doi:10.1155/2007/78171 · Cited by 65
“Consistent with this, spatial learning induces BDNF and trkB expression in activated brain areas, while BDNF inactivation markedly impairs spatial learning [32, 165].”
BackgroundPostnatal Loss of Mef2c Results in Dissociation of Effects on Synapse Number and Learning and Memory
Adachi, M., Lin, P.-Y., Pranav, H., & Monteggia, L. M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.09.018 · Cited by 53
“In previous work we analyzed the patterns of Cre-mediated recombination in the central nervous system of the CaMKII-Cre (used in the present study) and hGFAP-Cre (used to generate the embryonic KO mice) transgenic lines by crossing to reporter mice and found that both lines mediate recombination in a spatially restric…”
Self-citationPre-clinical investigations of β-carboline alkaloids as antidepressant agents: A systematic review
Ferraz, C. A. A., Júnior, R. G. D. O., Picot, L., Almeida, J. R. G. D. S., & Nunes, X. P. (2019) · Fitoterapia · doi:10.1016/j.fitote.2019.104196 · Cited by 65
Acupuncture – Self-Appraisal and the Reward System
Lundeberg, T., Lund, I., & Näslund, J. (2007) · Acupuncture in Medicine · doi:10.1136/aim.25.3.87 · Cited by 57
Vecsler, M., Zeev, B. B., Nudelman, I., Anikster, Y., Simon, A. J., Amariglio, N., Rechavi, G., Baasov, T., & Gak, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020733 · Cited by 54
“BDNF is the one of the most important MeCP2 targets, being crucially involved both, in synaptic plasticity during brain development [50] and in adults [51].”
BackgroundLasky-Su, J. A., Faraone, S. V., Lange, C., Tsuang, M. T., Doyle, A. E., Smoller, J. W., Laird, N. M., & Biederman, J. (2007) · Behavior Genetics · doi:10.1007/s10519-006-9136-x · Cited by 63
“When BDNF is eliminated from the brain after birth or in the early stages of development in mice mutants, the mice are hyperactive (Monteggia et al. 2004; Rios et al. 2001).”
BackgroundHou, X.-Y., Hu, Z., Zhang, D.-Z., Lu, W., Zhou, J., Wu, P.-F., Guan, X., Han, Q.-Q., Deng, S., Zhang, H., et al. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6737 · Cited by 54
“BDNF is linked to the traditional antidepressant action, and BDNF deletion in the hippocampus attenuates anti-depressant behavioral responses (2, 32).”
McPhee, G. M., Downey, L. A., & Stough, C. K. K. (2020) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2020.107298 · Cited by 65
Objectively measured physical activity and cognitive functioning in breast cancer survivors
Marinac, C. R., Godbole, S., Kerr, J., Natarajan, L., Patterson, R. E., & Hartman, S. J. (2015) · Journal of Cancer Survivorship · doi:10.1007/s11764-014-0404-0 · Cited by 51
“[39–41] In humans, physical activity interventions have demonstrated that peripheral BDNF concentrations are elevated significantly in response to both acute (single-bout of exercise) [42–44] and sustained exercise regimens.”
BackgroundAge dependence of the rapid antidepressant and synaptic effects of acute NMDA receptor blockade
Nosyreva, E., Autry, A. E., Kavalali, E. T., & Monteggia, L. M. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00094 · Cited by 51
Self-citationRodent models of treatment-resistant depression
Caldarone, B. J., Zachariou, V., & King, S. L. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.10.063 · Cited by 50
“…(cortex and hippocampus) knockout mice Attenuated antidepressant response to desipramine in the FST No, ketamine inactive in FST Autry et al. (2011), Monteggia et al. (2004), Monteggia et al. (2007) Regulator of G protein Signaling 4 (RGS4) constitutive and nucleus accumbens knockout Reduced…”
BackgroundBoger, H. A., Mannangatti, P., Samuvel, D. J., Saylor, A. J., Bender, T. S., McGinty, J. F., Fortress, A. M., Zaman, V., Huang, P., Middaugh, L. D., et al. (2011) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2010.00654.x · Cited by 50
“The elevated bodyweights seem to require a general BDNF reduction as it did not occur when restricted to the forebrain in a conditional KO mouse (Monteggia et al. 2004).”
BackgroundThe Influence of Prebiotics on Neurobiology and Behavior
Kao, A. C.-C., Harty, S., & Burnet, P. W. J. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.08.007 · Cited by 59
Schizophrenia and neurogenesis: A stem cell approach
Iannitelli, A., Quartini, A., Tirassa, P., & Bersani, G. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.06.010 · Cited by 56
Dynamic Expression and the Role of BDNF in Exercise-induced Skeletal Muscle Regeneration
Yu, T., Chang, Y., Gao, X., Li, H., & Zhao, P. (2017) · International Journal of Sports Medicine · doi:10.1055/s-0043-118343 · Cited by 55
“Brain-derived neurotrophic factor (BDNF) is also a myokine, although it belongs to the neurotrophin family [22] and was first found present in the nervous system, where it regulates neuronal survival, cell growth, synapses formation and transmission plasticity [17, 25, 31].”
BackgroundHensler, J. G., Advani, T., & Monteggia, L. M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.015 · Cited by 62
Self-citationChase, T. D., CARREY, N. J., Soo, E. C., & Wilkinson, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.10.035 · Cited by 58
Mechanisms of antidepressant action: An integrated dopaminergic perspective
Porcelli, S., Drago, A., Fabbri, C., & Serretti, A. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.005 · Cited by 58
Taliaz, D., Nagaraj, V., Haramati, S., Chen, A., & Zangen, A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.07.025 · Cited by 54
“mportantly, while the antidepressant-like effect of desipramine nd citalopram in the FST are blocked by DG BDNF KD (7,11), the ntidepressant-like effect of ECT was not blocked by dDG BDNF KD, s the FST scores in this group were not significantly reduced and ven tended to increase relative to the control LV sham group…”
BackgroundCaregiver maltreatment causes altered neuronal DNA methylation in female rodents
Blaze, J., & Roth, T. L. (2017) · Development and Psychopathology · doi:10.1017/s0954579417000128 · Cited by 48
“Animals with decreased Bdnf levels show impairments in long-term potentiation and hippocampal-dependent memory (Monteggia et al., 2004) along with abnormal cortical dendrite structure (Gorski, Zailer, Tamowski, & Jones, 2003) and impaired neurogenesis (Lee, Duan, & Mattson, 2002).”
BackgroundNeurotrophin-targeted therapeutics: A gateway to cognition and more?
Nordvall, G., Forsell, P., & Sandin, J. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.07.003 · Cited by 48
A review of type 2 diabetes mellitus and cognitive impairment
Kan, W., Qu, M., Wang, Y., Zhang, X., & Xu, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1624472 · Cited by 60
Chmielewski, W. X., & Beste, C. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.11.002 · Cited by 56
Consideration of the BDNF gene in relation to two phenotypes: Hoarding and obesity.
Timpano, K. R., Schmidt, N. B., Wheaton, M. G., Wendland, J. R., & Murphy, D. L. (2011) · Journal of Abnormal Psychology · doi:10.1037/a0024159 · Cited by 48
“The Val66Met variant leads to changes in BDNF protein distribution in the central nervous system, along with alterations in hippocampal size and function (Govindarajan et al., 2006; Monteggia et al., 2004).”
BackgroundAdachi, M., Autry, A. E., Mahgoub, M., Suzuki, K., & Monteggia, L. M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.201 · Cited by 52
“The dentate gyrus is innervated by serotonergic neurons projecting from the DRN (Adachi et al, 2009; Monteggia et al, 2004), consistent with the idea that BDNF secreted from the dentate gyrus is activating TrkB receptors on DRN neurons to mediate antidepressant efficacy.”
BackgroundMethodResultSelf-citationD’Addario, C., Bellia, F., Benatti, B., Grancini, B. M., Vismara, M. E. M., Pucci, M., Carlo, V. D., Viganò, C. A., Galimberti, D., Fenoglio, C., et al. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.04.006 · Cited by 49
BDNF as a Mediator of Antidepressant Response: Recent Advances and Lifestyle Interactions
Cubillos, S., Engmann, O., & Brancato, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214445 · Cited by 47
“Still, an attenuated response to the tricyclic antidepressant desipramine was observed [34], further indicating that forebrain BDNF was required for antidepressant efficacy.”
BackgroundDeyama, S., & Kaneda, K. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109335 · Cited by 49
Ibrahim, L., Duncan, W., Luckenbaugh, D. A., Yuan, P., Machado-Vieira, R., & Zarate, C. A. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.06.003 · Cited by 47
Major depression: emerging therapeutics
Sen, S., & Sanacora, G. (2008) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20043 · Cited by 47
Di Lieto, A., Rantamäki, T., Vesa, L., Yanpallewar, S., Antila, H., Lindholm, J., Rios, M., Tessarollo, L., & Castrén, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032869 · Cited by 47
“For example, loss of BDNF produces clear behavioural effects in adulthood [20,38,39].”
Antidepressant-like effects of a novel curcumin derivative J147: Involvement of 5-HT1A receptor
Lian, L., Xu, Y., Zhang, J., Yu, Y., Zhu, N., Guan, X., Huang, H., Chen, R., Chen, J., Shi, G., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.04.003 · Cited by 51
Soga, T., Teo, C. H., & Parhar, I. S. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.601868 · Cited by 51
Roles of Gasotransmitters in Synaptic Plasticity and Neuropsychiatric Conditions
Shefa, U., Kim, D., Kim, M., Jeong, N. Y., & Jung, J. (2018) · Neural Plasticity · doi:10.1155/2018/1824713 · Cited by 51
“BDNF induces traditional antidepressant actions, and BDNF deletion in the hippocampus weakens antidepressant behavioral responses [71].”
BackgroundLarsen, M. H., Rosenbrock, H., Sams‐Dodd, F., & Mikkelsen, J. D. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.10.029 · Cited by 48
Benekareddy, M., Nair, A. R., Dias, B. G., Suri, D., Autry, A. E., Monteggia, L. M., & Vaidya, V. A. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000168 · Cited by 45
“Inducible BDNF KO mice have been previously shown to exhibit a significant decline in BDNF mRNA and protein within the neocortex and the hippocampus (y70 %), with residual levels of BDNF still observed due to the nature of recombination, which does not occur in every neuron (Monteggia et al. 2004).”
BackgroundMethodInfluentialSelf-citationBorralleras, C., Sahún, I., Jurado, L. A. P., & Campuzano, V. (2015) · Molecular Therapy · doi:10.1038/mt.2015.130 · Cited by 56
Jaramillo, T. C., Xuan, Z., Reimers, J. M., Escamilla, C. O., Liu, S., & Powell, C. M. (2020) · eNeuro · doi:10.1523/eneuro.0332-19.2020 · Cited by 50
“Second, based on many published reports including our own (Monteggia et al., 2004), we anticipated that breeding and rearing mice on doxycycline-containing water would successfully suppress tTA activation of cre-recombinase expression so that we might use doxycycline withdrawal Figure 4.”
BackgroundInfluentialSelf-citationMeng, F., Liu, J., Dai, J., Wu, M., Wang, W., Liu, C., Zhao, D., Wang, H., Zhang, J., Li, M., et al. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.05.003 · Cited by 48
Costa, R. O., Martins, L. F., Tahiri, E., & Duarte, C. B. (2022) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1713 · Cited by 47
Niciu, M. J., Ionescu, D. F., Mathews, D. C., Richards, E. M., & Zarate, C. A. (2013) · CNS Spectrums · doi:10.1017/s1092852913000059 · Cited by 43
“Conditional BDNF knockout in the mouse forebrain impairs the antidepressant effects of desipramine on the forced swim test (FST).(20) As a result, CNS BDNF expression is both necessary (based on inducible knockout experiments) and sufficient (from exogenous administration experiments) for antidepressant efficacy.”
BackgroundBergman, O., Westberg, L., Lichtenstein, P., Eriksson, E., & Larsson, H. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000502 · Cited by 43
“Moreover, loss of Bdnf in broad forebrain regions in mice during early stages of development causes hyperactivity as well as pronounced hippocampal-dependent learning deficits (Monteggia et al. 2004).”
BackgroundRegulatory role of NGFs in neurocognitive functions
Kumar, A., Pareek, V., Faiq, M. A., Kumar, P., Raza, K., Prasoon, P., Dantham, S., & Mochan, S. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0031 · Cited by 47
CHEN, J., Kitanishi, T., IKEDA, T., MATSUKI, N., & Yamada, M. K. (2007) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.07.009 · Cited by 47
“Brain-derived neurotrophic factor (BDNF), a secretory protein expressed mainly in excitatory neurons, is a major candidate molecule for participation in contextual memory formation (Liu, Lyons, Mamounas, & Thompson, 2004; Monteggia et al., 2004).”
BackgroundHemodialysis Decreases Serum Brain-Derived Neurotrophic Factor Concentration in Humans
Zoladz, J. A., Śmigielski, M., Majerczak, J., Nowak, Ł. R., Zapart-Bukowska, J., Smoleński, O., Kulpa, J., Duda, K., Drzewińska‐Chańko, J., & Bartosz, G. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0862-6 · Cited by 46
“Since BDNF plays a critical role in the functioning of the brain [2, 22, 23], some authors have attempted to relate the BDNF with major mental disorders including depression [24, 25] and schizophrenia [26].”
BackgroundIntranasal insulin-like growth factor I (IGF-I) as a plausible future treatment of depression
Paslakis, G., Blum, W. F., & Deuschle, M. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.04.045 · Cited by 48
“[25,26].”
Sensitivity of hippocampal 5-HT1A receptors to mild stress in BDNF-deficient mice
Burke, T. F., Advani, T., Adachi, M., Monteggia, L. M., & Hensler, J. G. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000466 · Cited by 42
Self-citationHill, R. A., Murray, S. S., Halley, P. G., Binder, M. D., Martin, S. J., & van den Buuse, M. (2011) · Hippocampus · doi:10.1002/hipo.20759 · Cited by 41
“, 2007) and decreased (Kernie et al., 2000; Rios et al., 2001; Monteggia et al., 2004) BDNF levels with locomotor hyperactivity.”
BackgroundAge-dependent deficits in fear learning in heterozygous BDNF knock-out mice
Endres, T., & Lessmann, V. (2012) · Learning & Memory · doi:10.1101/lm.028068.112 · Cited by 41
“Results of studies using inducible BDNF-KO mouse lines are quite diverse: Inducible KO animals with forebrain-restricted decreased BDNF levels (including the BLA) revealed impaired cued fear learning when KO induction started before birth, but not if KO induction started in adult animals (Monteggia et al. 2004).”
BackgroundAntidepressant-like effect of food-derived pyroglutamyl peptides in mice
Yamamoto, Y., Mizushige, T., Mori, Y., Shimmura, Y., Fukutomi, R., Kanamoto, R., & Ohinata, K. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.04.002 · Cited by 40
“Since BDNF is known to induce both hippocampal neurogenesis and antidepressant-like effect (Li et al., 2008; Monteggia et al., 2004; Shirayama et al., 2002), we also tested the involvement of BDNF in the antidepressant-like effect of pyroglutamyl peptide.”
BackgroundWhy Woody got the blues: The neurobiology of depression in Huntington's disease
Gubert, C., Renoir, T., & Hannan, A. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104958 · Cited by 42
Targeting TrkB neurotrophin receptor to treat depression
Rantamäki, T., & Castrén, E. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.6.705 · Cited by 40
“Moreover, BDNF-deficient mice do not respond to antidepressant drugs in rodent ‘depression’ models [49,50] whereas infusion of BDNF to the rodent midbrain or hippocampus produces antidepressant-like behavioral phenotypes in models of behavioral despair [51,52] .”
BackgroundGenetics and Functional Imaging: Effects of APOE, BDNF, COMT, and KIBRA in Aging
Papenberg, G., Salami, A., Persson, J., Lindenberger, U., & Bäckman, L. (2015) · Neuropsychology Review · doi:10.1007/s11065-015-9279-8 · Cited by 39
“Indeed, knockout-mouse experiments demonstrate that adult mice lacking BDNF exhibit hippocampal-dependent learning deficits (Monteggia et al. 2004).”
BackgroundWu, R., Tao, W., Zhang, H., Xue, W., Zou, Z., Wu, H., Cai, B., Doron, R., & Chen, G. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00011 · Cited by 40
Dagestad, G., Kuipers, S. D., Messaoudi, E., & Bramham, C. R. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04817.x · Cited by 38
“Recent animal studies show that upregulation of BDNF gene expression and enhanced signalling of BDNF through its TrkB receptor tyrosine kinase is necessary for the behavioural effects of chronically administered SSRIs and other antidepressant drugs (Saarelainen et al., 2003; Monteggia et al., 2004).”
BackgroundMicroRNA-206 Regulates Stress-Provoked Aggressive Behaviors in Post-weaning Social Isolation Mice.
Chang, C.-H., Kuek, E. J. W., Su, C.-L., & Gean, P.-W. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.05.001 · Cited by 35
“Although preclinical and clinical studies suggest that BDNF is critically involved in antidepressants, some controversial studies show that mice with adulthood BDNF knockdown do not exhibit baseline depression-like behavior.(25,26) It is currently accepted that BDNF is critical for antidepressant effects but not neces…”
BackgroundNucleus accumbens in the pathogenesis of major depressive disorder: A brief review
Yajie, J., Zou, M., Wang, Y., & Wang, Y. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.03.004 · Cited by 43
“monoamine transmitter system (11-13), lack of neurotrophin (14-17),etc.”
Signaling Pathways Involved in Antidepressant-Induced Cell Proliferation and Synaptic Plasticity
Pilar-Cuéllar, F., Vidal, R., Díaz, Á., Castro, E., Dos-Anjos, S., Vargas, V. I., Romero, B., & Valdizán, E. M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660736 · Cited by 40
Ma, J., Wang, F., Yang, J., Dong, Y., Su, G., Zhang, K., Pan, X., Ma, P., Zhou, T.-S., & Wu, C. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.07.005 · Cited by 40
Pathologic role of nitrergic neurotransmission in mood disorders
Ghasemi, M., Claunch, J. D., & Niu, K. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.06.002 · Cited by 38
D'Amore, D. E., Tracy, B. A., & Parikh, V. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.033 · Cited by 42
Intracranial gene delivery of LV‐NAGLU vector corrects neuropathology in murine MPS IIIB
Domenico, C. D., Villani, G. R. D., Napoli, D. D., Nusco, E., Calì, G., Nitsch, L., & Natale, P. D. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32861 · Cited by 48
“The loss of Bdnf during development causes hyperactivity and more pronounced hippocampal-dependent learning deficits [Monteggia et al., 2004] as well as hippocampaldependent memory impairment [Barrientos et al., 2003].”
BackgroundMolecular and genetic basis of depression
ROY, M., Tapadia, M. G., Joshi, S., & Koch, B. (2014) · Journal of Genetics · doi:10.1007/s12041-014-0449-x · Cited by 45
BDNF-Deficient Mice Show Reduced Psychosis-Related Behaviors Following Chronic Methamphetamine
Manning, E. E., Halberstadt, A. L., & van den Buuse, M. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv116 · Cited by 37
“BDNF plays a critical role in neuroplasticity in the adult brain (Monteggia et al., 2004; Pu et al., 2006); therefore, BDNF may also be involved in the development of persistent behavioral changes relevant to psychosis following METH abuse.”
BackgroundConner, A. C., Kissling, C., Hodges, E., Hünnerkopf, R., Clement, R. M., Dudley, E., Freitag, C. M., Rösler, M., Retz, W., & Thome, J. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30632 · Cited by 36
“Neurotrophins have been shown to play a possible role in the pathophysiology of ADHD in a study of BDNF gene knockout mice [Monteggia et al., 2004; Monteggia et al., 2007].”
BackgroundCastello, N. A., Green, K. N., & LaFerla, F. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039566 · Cited by 36
Kuhn, M., Weidenauer, A., & Pezawas, L. (2014) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-139005 · Cited by 45
“These findings are in line with animal studies highlighting a specific role of BDNF in the preservation of hippocampal functional integrity that is related to memory processing and depressive mood (Heldt et al., 2007; Molendijk et al., 2012b; Monteggia et al., 2004; Saxe et al., 2006).”
ResultShah, A. P., Carreno, F. R., Wu, H., Chung, Y. A., & Frazer, A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.024 · Cited by 38
“, 2008), our results with acute treatment with DMI and VNS in the FST in rats suggest a critical role for TrkB activation in the AD-like effects of these treatments and are consistent with the lack of effect of drugs in the FST in BDNF heterozygote knockout mice (Saarelainen et al., 2003; Monteggia et al., 2004) and i…”
BackgroundResultPsychiatric Disorders - Trends and Developments
(2011) · InTech eBooks · doi:10.5772/2330 · Cited by 35
van Calker, D., Serchov, T., Normann, C., & Biber, K. P. H. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.03.014 · Cited by 36
“…other hand genetic knockout or reduction of BDNF or TrkB did not result in depressive-like behavior, findings not supporting a crucial role of BNDF levels for the development of depressive-like behavior (Castren, 2014; MacQueen et al., 2001; Monteggia et al., 2004, 2007; Saarelainen et al., 2003).”
ResultDipeptide tyrosyl-leucine exhibits antidepressant-like activity in mice
Mizushige, T., Uchida, T., & Ohinata, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-59039-7 · Cited by 37
Neurotrophin signalling in amygdala-dependent cued fear learning
Meis, S., Endres, T., & Leßmann, V. (2020) · Cell and Tissue Research · doi:10.1007/s00441-020-03260-3 · Cited by 43
Tamburella, A., Micale, V., Leggio, G. M., & Drago, F. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.04.006 · Cited by 37
“Furthermore, whilst BDNF infusion in the hippocampus exerts antidepressant properties in the FST and learned helplessness paradigms (Shirayama et al., 2002), mice lacking BDNF fail to have antidepressant responses (Monteggia et al., 2004).”
Creed, M. C., Hamani, C., & Nóbrega, J. N. (2012) · Brain stimulation · doi:10.1016/j.brs.2012.09.012 · Cited by 41
“This decrease in BDNF is responsive to antidepressant treatment, and is thought to contribute to antidepressant response [55,56].”
Du, X., Pang, T. Y., & Hannan, A. J. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00081 · Cited by 38
“In BDNF-deficient mice, the behavioral effects of antidepressants were abolished (Saarelainen et al., 2003; Monteggia et al., 2004).”
BackgroundRegulation of brain-derived neurotrophic factor (BDNF) during sleep apnoea treatment
Staats, R., Stoll, P., Zingler, D., Virchow, J. C., & Lommatzsch, M. (2005) · Thorax · doi:10.1136/thx.2004.038208 · Cited by 37
“7 It induces long term changes in synaptic composition, ion channel expression, and neurotransmitter production in neuronal structures of the brain.”
BackgroundJha, S., Dong, B. E., Xue, Y., Delotterie, D. F., Vail, M. G., & Sakata, K. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.160 · Cited by 33
Angelucci, F., Croce, N., Spalletta, G., Dinallo, V., Gravina, P., Bossù, P., Federici, G., Caltagirone, C., & Bernardini, S. (2011) · Pharmacology · doi:10.1159/000322528 · Cited by 33
“Consistently, transgenic mice with impaired BDNF synthesis fail to respond to antidepressant drugs [”
BackgroundCampos, C., Rocha, N., Lattari, E., Nardi, A. E., & Machado, S. E. D. C. (2017) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666161223142918 · Cited by 37
Candidate genes for panic disorder: insight from human and mouse genetic studies
Gratacòs, M., Sahún, I., Gallego, X., Amador‐Arjona, A., Estivill, X., & Dierssen, M. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00318.x · Cited by 36
“…the most robust evidence for the involvements of BDNF in anxiety comes from the studies on different genetically modified mouse models of BDNF or TrkB has also pointed to a role of this NT in emotional behavior (Lyons et al. 1999; MacQueen et al. 2001; Monteggia et al. 2004; Rios et al. 2001).”
BackgroundДыгало, Н. Н., Kalinina, T. S., Bulygina, V. V., & Shishkina, G. T. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9794-y · Cited by 35
“per se was not sufficient to produce a depression-like behavior (Adachi et al. 2008; Monteggia et al. 2004), as”
BackgroundRapid antidepressant effects: moving right along
Martinowich, K., Jimenez, D. V., Zarate, C. A., & Manji, H. K. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.55 · Cited by 32
Gardier, A. M., Guiard, B. P., Guilloux, J., Repérant, C., Coudoré, F., & David, D. J. P. (2009) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00640.x · Cited by 40
“Monteggia et al. (2004) [113] used an inducible KO system to show that deleting BDNF in broad forebrain regions of adult mice attenuates the effects of desipramine, an antidepressant, in the FST, connecting the BDNF role in adult brain with the antidepressant-like activity of these drugs.”
MethodMa, Y., Liu, M., Yang, L., Zhang, L., Guo, H., Qin, P., & Hou, W. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01960-z · Cited by 34
VGF, a New Player in Antidepressant Action?
Malberg, J. E., & Monteggia, L. M. (2008) · Science Signaling · doi:10.1126/stke.118pe19 · Cited by 30
Self-citationThe modifier effect of the BDNF gene in the phenotype of the WAGRO syndrome
Rodríguez‐López, R., Pérez, J. M. C., Balsera, A. M., Rodríguez, G. G., Moreno, T. H., de Cáceres, M. G., González‐Carpio, M., Casanueva, F. F., González, J. R., Barros, F., et al. (2012) · Gene · doi:10.1016/j.gene.2012.11.073 · Cited by 30
Sierksma, A. S. R., Vanmierlo, T., Vry, J. D., Raijmakers, M., Steinbusch, H. W. M., van den Hove, D., & Prickaerts, J. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.06.022 · Cited by 31
Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?
Carboni, E., Carta, A. R., Carboni, E., & Novelli, A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.657714 · Cited by 35
Woodburn, S. C., Asrat, H. S., Flurer, J. K., Schwierling, H. C., Bollinger, J. L., Vollmer, L. L., & Wohleb, E. S. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.01.014 · Cited by 32
Guo, F., Zhang, Q., Zhang, B., Fu, Z., Wu, B., Huang, C., & Li, Y. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12725 · Cited by 29
Jeong, H. I., Ji, E., Kim, S., Kim, T.-W., Baek, S.-B., & Choi, S. W. (2014) · Journal of Exercise Rehabilitation · doi:10.12965/jer.140111 · Cited by 29
“Loss of BDNF during earlier stages of development caused hyperactivity and more pronounced hippocampal-dependent learning deficits (Monteggia et al., 2004).”
BackgroundBDNF heterozygous mice demonstrate age-related changes in striatal and nigral gene expression
Saylor, A. J., Meredith, G. E., Vercillo, M. S., Zahm, D. S., & McGinty, J. F. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.01.004 · Cited by 34
Metadata
- Authors
- Monteggia, L. M., Barrot, M., Powell, C. M., Berton, O., Galanis, V., Gemelli, T., Meuth, S., Nagy, A., Greene, R. W., & Nestler, E. J.
- Affiliations
- Mount Sinai Hospital (CA)
- Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390-9070; and Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada M5G 1X5
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-07-12
- Volume
- 101
- Issue
- 29
- Pages
- 10827-10832
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC490019
- OpenAlex
- W2078035790
- Cited by
- 685
- References
- 33
- Citations by year
- 2026: 16 · 2025: 12 · 2024: 20 · 2023: 15 · 2022: 29 · 2021: 23 · 2020: 23 · 2019: 35 · 2018: 35 · 2017: 29 · 2016: 34 · 2015: 34 · 2014: 36 · 2013: 44 · 2012: 42
- FWCI
- 12.45
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- National Institute of Mental Health (K08MH065975)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- brain-derived neurotrophic factor, hippocampus, hippocampus-dependent learning, long-term potentiation, inducible knockout, forebrain, hyperactivity, antidepressant efficacy, desipramine, forced swim test
- MeSH terms
- Animals, Antidepressive Agents, Tricyclic, Desipramine, Electrophysiology, Hippocampus, Learning, Motor Activity, In Situ Hybridization, Mice, Knockout, Brain-Derived Neurotrophic Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.